Stimuli-responsive CBHs are the major component of drug delivery systems (DDSs) made of CBHs, having been well researched and widely applied, for they are liable to gelatinize and break down under definite stimuli. In addition, their widespread application can be attributed to their injectability, lack of surgical necessity, shape flexibility,
etc. They can release drugs, cells, biomass,
etc. at one specific occasion, depending on the microenvironment of the tissue, including pH values, temperature, biological factors,
etc. [
70]. Passively received and steerable stimuli could be used to categorize these signals. The former should be nimble and take into account the hardwired circumstances of the target site, due to the fact that the former is a category of indeterminate parameters, whereas the latter can be regulated because it is generally stable and mostly factitious. As detailed in the tissue engineering part, at an acidic pH, the amino groups of chitosan will be positively charged, and hydrogel will swell, facilitating the release of cargo. But most of the groups were depleted by chemical gelation. Silva
et al. [
71] preserved the original amino acid
via a protecting and deprotecting strategy. The physical crosslinking approach is another practical option. It can retain relatively high pH sensitivity and fragility, which are advantageous for the emancipation of medications. It's been demonstrated that sol-gel crosslinking CBH is a pH-responsive matrix that can bulge or dwindle depending on the pH level of the microenvironment [
72]. In cancer therapy, the drugs used in DDSs are usually malignant to normal cells as well. The gel formation is rather immobile, favoring adhesion to the targeted tissue by filling it up or wrapping it. Then, different stimuli foster the release of bioactive molecules integrated with chitosan, achieving targeted therapy. The tumor microenvironment (TME) is a multifaceted and continuously evolving object, featuring acidic, hypoxic, excessive metabolite accumulation, and high-depression conditions for immune cells [
73,
74]. pH-responsive CBHs, especially acid-sensitive ones, would trigger degradation of the hydrogel there [
75], thereby releasing the loaded drugs. Another latent reaction, swelling behavior, triggered by acidic stimuli, increases the contact area between the hydrogel and the tumor, facilitating the diffusion of drugs or other agents from the hydrogel [
70]. Besides, it can also exert mechanical pressure on the tumor tissue, depressing and hindering tumor growth. The high density of lactic acid in the tissue fluid promotes macrophage transformation into M2 type, which will foster the escalation of tumors [
76]. The immunosuppressive milieu can be reversed in the microenvironment by adding CaCO3, which also lessens the immunosuppressive effect on T cells since the higher pH value encourages macrophage polarization from M2 type to M1 type [
77]. And the bionic onion structure is applied to regulate the drug release kinetics [
78]. It enlightens that the exquisite structure can be programmed to release alkaline salts or ions in acidic instances before setting free medications, which are not only stimuli-responsive but also can adjust the microenvironment to favor subsequent treatment. Thermo-sensitive CBHs can be divided into two types. One form of thermo-sensitive CBH exhibits a lower critical solution temperature (LCST), whereas the other type exhibits an upper critical solution temperature (UCST). When the temperature is raised over a certain degree, LCST hydrogel contracts and releases contents, whereas UCST hydrogel expands and absorbs water. LCST could be exploited to control the release of drugs from the hydrogel, for the hydrogel will shrink and release encapsulated drugs within it [
79]. By controlling the temperature and the LCST of the CBHs, it is achievable to control the rate and timing of drug release. Comparatively, the delivery mode of
in situ-forming hydrogel is the very opposite of the anterior. UCST hydrogel is a fluid that facilitates a mixture with drugs at a lower temperature and becomes gel after being inoculated into the body. Incidentally, the UCST CBH is widely utilized as a category of injectable hydrogel. The liquid formation facilitates the homogeneous incorporation of drugs or biological molecules, and they can keep their hydrogel formation after injection, achieving relatively sustained drug release. Vaccine antigens could be added when the hydrogel is liquid at room temperature and can be released slowly to trigger the adaptive immune system [
80]. Wu
et al. [
81] creatively synthesized hydrogel
via ascending the temperature break of the LCST, and it’s promising to prepare DDS. Hydrogels that are light-sensitive have a variety of methods to release their cargo. One method involves the photothermal effect, in which near-infrared light can cause a specific cargo to be released, leading to the creation of hydrogel [
82]. The release of cargo can also occur through photo-initiated chemical processes, which could alter the hydrogel network [
83]. Nevertheless, these CBHs only respond to one parameter, and it’s vital to control or maintain other conditions during the preparation and application phases, limiting their potential applications and controlling their behavior. Multi-responsive CBHs are hydrogels that can respond to more than one stimulus from the environment. They can control drug release precisely and lessen side effects thanks to their benefits like diverse sensitivities, expected kinetics, easier degradability under particular conditions,
etc. [
84]. Nisar
et al. [
85] synthesized a UV- and pH-sensitive DCC hydrogel
via the Schiff base reaction, forming imine bonds. Nonetheless, the synthesis procedure is complicated and more likely to retain harmful chemical agents. Theoretically, because physical crosslinking CBHs are fragile structures, it is possible to create them, excluding the latter hidden problem, but it is challenging to manage how they degrade in response to particular stimuli. The swift release mechanism, which is appropriate for rapid onset or potent drugs. The opposite can release with a relatively average velocity and preserve stability under some conditions, which is preferable to drugs that only need to maintain low consistency and a sustained release over a longer period of time. And by avoiding the high peak density of medications in the body, sustained release can also aid in lessening adverse effects and damage to contiguous tissues. Except for UCST and multi-network [
86,
87] CBHs, sustained release can be tunable
via self-digestion or hydrolysis. Lysozyme can act as a crosslinker and a drug carrier for chitosan sulfate hydrogels, and the release kinetics of drugs can be modified by adjusting the lysozyme concentration [
88]. The hydrolysis of the azomethine linkages in the polyurethane chains led to the degradation of the hybrid hydrogels [
89].